Victor Aboyans

Dados Biográficos

ID	10703013
NOME	Victor Aboyans
PRENOMES	Victor
SOBRENOME	Aboyans
ASSINATURA	ABOYANS V
AFILIAÇÕES	University of Washington
ORCID	0000-0002-0322-9818
VERIFICADO	Não
TOTAL DE OBRAS	30
TOTAL DE CITAÇÕES	0
TOTAL COMO AUTOR	30
TOTAL COMO EDITOR	0
PRIMEIRO ANO DE PUBLICAÇÃO	2012
ANO MAIS RECENTE DE PUBLICAÇÃO	2024
ÍNDICE H	0

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021
Open AccessJaimie D Steinmetz, Katrin Seeher et al.ARTICLEThe Lancet Neurology2024
BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Open AccessTheresa A McDonagh, Marco Metra et al.ARTICLEEuropean Heart Journal2021
peer reviewed
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019
Open AccessMarissa B Reitsma, Parkes J Kendrick et al.ARTICLEThe Lancet2021
BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…
ESC Guidelines on cardiovascular disease prevention in clinical practice
Open AccessFrank L J Visseren, François Mach et al.ARTICLEEuropean Heart Journal2021
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to goo…
Five insights from the Global Burden of Disease Study 2019
Open AccessChristopher J L Murray, Cristiana Abbafati et al.ARTICLEThe Lancet2020
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Open AccessGregory A Roth, George A Mensah et al.ARTICLEJournal of the American College…2020
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…
Global burden of 87 risk factors in 204 countries and territories, 1990–2019
Open AccessChristopher J L Murray, Aleksandr Y Aravkin et al.ARTICLEThe Lancet2020
BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
Open AccessTheo Vos, Stephen S Lim et al.ARTICLEThe Lancet2020
BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…
Global, regional, and national burden of neurological disorders, 1990–2016
Open AccessValery L Feigin, Emma Nichols et al.ARTICLEThe Lancet Neurology2019
BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017
Open AccessDaniel Dicker, Grant Nguyen et al.ARTICLEThe Lancet2018
BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…
ESC/ESH Guidelines for the management of arterial hypertension
Open AccessBryan Williams, Giuseppe Mancia et al.ARTICLEEuropean Heart Journal2018
The current background information and detailed discussion of the data can be found in ESC CardioMed - Section 44 Systemic hypertension ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily pr…
Alcohol use and burden for 195 countries and territories, 1990–2016
Open AccessMax Griswold, Max G Griswold et al.ARTICLEThe Lancet2018
BACKGROUND: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjus…
Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017
Open AccessHmwe Hmwe Kyu, D Abate et al.ARTICLEThe Lancet2018
BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations
Open AccessNancy Fullman, Jamal A Yearwood et al.ARTICLEThe Lancet2018
BACKGROUND: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthc…
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories
Open AccessR Lozano, Nancy Fullman et al.ARTICLEThe Lancet2018
BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries
Open AccessNancy Fullman, Ryan M Barber et al.ARTICLEThe Lancet2017
BACKGROUND: The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of "leaving no one behind". Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990-2016 for 188…
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016
Open AccessTheo Vos, Amanuel Alemu Abajobir et al.ARTICLEThe Lancet2017
BACKGROUND: As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. METHO…
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016
Open AccessMohsen Naghavi, Amanuel Alemu Abajobir et al.ARTICLEThe Lancet2017
BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns …
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016
Open AccessEmmanuela Gakidou, Ashkan Afshin et al.ARTICLEThe Lancet2017
BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of risk factor exposure and attributable burden of disease. By providing estimates over a long time series, this study can monitor risk exposure trends critical to health surveillance and inform policy debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework dev…
Global, regional, and national disability-adjusted life-years (Dalys) for 333 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2016
Open AccessSimon I Hay, Amanuel Alemu Abajobir et al.ARTICLEThe Lancet2017
BACKGROUND: Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: di…
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015
Open AccessHaidong Wang, Zulfiqar A Bhutta et al.ARTICLEThe Lancet2016
BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 …
Global, regional, and national levels of maternal mortality, 1990–2015
Open AccessNicholas J Kassebaum, Ryan M Barber et al.ARTICLEThe Lancet2016
BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015. METHODS: We estimated maternal mortality at the global, regional, …
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013
Open AccessMohammad H Forouzanfar, Lily Alexander et al.ARTICLEThe Lancet2015
Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013
Open AccessChristopher J L Murray, Ryan M Barber et al.ARTICLEThe Lancet2015
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013
Open AccessTheo Vos, Ryan M Barber et al.ARTICLEThe Lancet2015